Ravshan Sultanov

Ravshan Sultanov

Auto-generated profile, based on publicly available information

Ravshan Sultanov

Department of Morphological Sciences, Termez University of Economics and Service,Termez, Uzbekistan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in Cell Biochemistry and Biophysics
Verified
Journal Article
Closed access
PDF file
WAWajahat Ali
Wajahat Ali
ZSZainab Saba
Zainab Saba
MSMuhammad Saqib
Muhammad Saqib
SBShabana Batool
Shabana Batool
AWAwais
Awais
YUYuldoshev Jushkinbek Erkaboy Ugli
Yuldoshev Jushkinbek Erkaboy Ugli

22 August 2025 in Journal of Animal Environment
Verified
Journal Article
Open access
PDF file
IOIlkhom Otajonov
Ilkhom Otajonov
FSFeruza Sadriddinova
Feruza Sadriddinova
OEOzodbek Eshqobilov
Ozodbek Eshqobilov
GKGayrat Kodirov
Gayrat Kodirov
DMDedakhanov Abdumalik Mutalliyevich
Dedakhanov Abdumalik Mutalliyevich
RSRavshan Sultanov
Ravshan Sultanov
Climate change is a significant global health concern, and its effects on cardiovascular morbidity and mortality would be massive, particularly in vulnerable groups. This study depends on the analysis of the long-term impacts of climate change on the state of cardiovascular health by taking the vulnerable populations (the aged, low-income, those with pre-existing health conditions, etc.) as the primary objects. The simulate the association between the climate variables (extreme temperatures, air pollution, and regular monsoon flooding) and the cardiovascular outcomes (heart attacks, strokes, and other cardiovascular diseases) using data on a 20-year interval (20032023) of both rural and urban South Asia, which is one of the regions that climate stressors have greatly impactedssors. Advanced statistical models, such as time-series regression and distributed lag non-linear models (DLNMs), were used to determine the delayed and accrued effects of climate change on cardiovascular morbidity and mortality. The study discover that there is a close correlation between rising temperature and heavy air pollution, together with a rising rate of cardiovascular death, and also the higher rates of cardiovascular death are linked to the population with limited access to healthcare, and also to those populations located in flood-prone areas. Simultaneously, research on wildlife species has shown that climate-related stressors, including rising temperatures and air pollution, can cause cardiovascular stress and mortality. For example, heat stress in some animal species can cause elevated heart rates, cardiovascular strain, and increased mortality, similar to the effects on the human population. These results support the need to address human and animal health in climate change adaptation regulations. The findings of the study emphasize the idea that urgent actions that should be taken to create region-focused climate adaptation plans, including the improvement of the healthcare system, early intervention programs, air pollutants minimization strategy, etc., are required. The article provides novel insights into the consequences of climate change for long-term cardiovascular health in South Asia, contributing to the global discourse on climate change and underscoring the need to give special concern to public health in populations at risk.

25 June 2026 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
MBMayram Miralievna Boltaeva
Mayram Miralievna Boltaeva
ZSZafar Isomiddinovich Sanoev
Zafar Isomiddinovich Sanoev
TKTolmas Tolibovich Khamroev
Tolmas Tolibovich Khamroev
RSRavshan Komiljonovich Sultonov
Ravshan Komiljonovich Sultonov
SKSirojiddin Rashidovich Kenjaev
Sirojiddin Rashidovich Kenjaev
SRSokhib Zamonogli Rashidov
Sokhib Zamonogli Rashidov
CVD are the leading cause of death and disability worldwide and arrhythmias, in particular AF, are one of the main causes of death and disability from CVD. In this regard, the main purpose of the work is to conduct preclinical studies on the analysis of promising anti-ventricular fibrillation, as well as anti-atrial fibrillation among known drugs with antiarrhythmic activity, widely used in medical practice. The studies used white mice with a body weight of 18-22 g and white woolless rats with a body weight of 180-250 g. The experiments studied the antiarrhythmic activity of drugs with antiarrhythmic activity of allapinine in doses from 0.05 to 1.5 mg/kg, propafenone from 3 to 10 mg/kg and Amiodarone in doses from 45 to 60 mg/kg administered orally to experimental animals. Rhythm disturbances of peripheral origin were caused by the administration of 15 mg/kg of aconitine and barium chloride, 250 mg/kg of calcium chloride, 0.22 mcg/kg of adrenal hydrochloride and AF by injecting 200 mcg/kg of aconitine into the tail vein of experimental animals. In the conducted studies, allapinine, propafenone and amiodarone also primarily eliminated ventricular rhythm disturbances and then restored the rhythm of the atria. Although the instructions for the use of these drugs in clinical practice also mention ventricular rhythm disorders, in practice we see that these drugs mainly eliminate ventricular rhythm disorders. The quest for methods to broaden the scope of the use of medications that prevent AF is still relevant in medical practice, even though large-scale, important studies of antiarrhythmic pharmaceuticals are now being conducted worldwide.

28 June 2025 in Medical science of Uzbekistan
Verified
Journal Article
Open access
PDF file
RSRavshan Sultonov
Ravshan Sultonov
TQTuqtash Qurbonov
Tuqtash Qurbonov
GQGulnoza Qurbonova
Gulnoza Qurbonova
Whooping cough remains one of the leading causes of infant mortality worldwide. This article presents a comparative diagnosis of bronchopulmonary complications in young children infected with respiratory syncytial virus and pertussis virus. The study was conducted on 50 children with pertussis at the central polyclinic of Termez city, Surkhandarya region, during 2023-2024. All 50 children with whooping cough were divided into age groups as follows: 1-year-old children formed the 1st group, 2-year-old children formed the 2nd group, and 3-year-old children formed the 3rd group. When examining the disease by gender in the study: Bronchopulmonary complications in boys were categorized into subgroups based on the results of objective and instrumental examinations and were assessed as follows: Bronchopneumonia in 18 (36%) patients, acute bronchitis in 16 (32%) patients, laryngitis in 6 (12%) patients, and bronchitis+laryngitis in 9 (18%) patients. In girls, bronchopulmonary complications were studied by subgroups as follows: bronchopneumonia was observed in 6 (12%) patients, acute bronchitis in 16 (32%) patients, laryngitis in 15 (30%) patients, and bronchitis+laryngitis in 13 (26%) patients. In conclusion, among the bronchopulmonary complications in children with whooping cough, bronchopneumonia was observed in 38% of boys, while acute bronchitis was seen in 32% of girls. It was found that 30% of all examined patients were not vaccinated at all, of which 10% had not yet reached the age for vaccination. Whooping cough tends to be severe in children, mainly in early childhood (1-3 years old), due to incomplete vaccination against the disease. These cases require a special therapeutic approach.